Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Claudia Leitte, Ivete Sangalo e Sabrina Sato: musas do carnaval contam sua preparação para a data


News provided by

Galderma

Feb 13, 2023, 11:35 ET

Share this article

Share toX

Share this article

Share toX

Ícones do carnaval, as artistas se preparam para a celebração com rotina intensa de exercícios físicos, além da ajuda de procedimentos para realçar a beleza, como bioestimulador de colágeno e ácido hialurônico injetável

SÃO PAULO, 13 de fevereiro de 2023 /PRNewswire/ -- O que Claudia Leitte, Ivete Sangalo e Sabrina Sato têm em comum? Além de muito alto astral e beleza, as musas também contam com a ajuda de alguns procedimentos pontuais para manter a pele saudável e a autoestima elevada com o passar dos anos. E agora, com o Carnaval batendo à porta, elas intensificam esses cuidados com o bioestimulador de colágeno Sculptra® e o ácido hialurônico Restylane®, exercício físico, alimentação saudável, entre outros hábitos.

Continue Reading
esquerda à direita – Robson Senne, Rafa Mattei, Fernando Tomaz
esquerda à direita – Robson Senne, Rafa Mattei, Fernando Tomaz

"Quem já viu um show meu, sabe que não paro um minuto, então, sempre fiz muitas atividades físicas para dar conta dessas maratonas. Com o passar do tempo, nosso corpo vai perdendo a capacidade de produzir colágeno e, mesmo eu mantendo essa rotina de exercícios, percebi que tinham partes do meu corpo que podiam ganhar uma ajudinha extra para ficarem mais firmes. Foi então que passei a frequentar um profissional de saúde para um tratamento com o bioestimulador de colágeno Sculptra® na face e no corpo, em áreas como abdômen, coxas e bumbum, para ajudar a ativar meu próprio corpo a voltar a produzir colágeno. O que eu acho mais interessante do produto é que, por ele ativar no corpo esse poder de produzir mais colágeno, o resultado fica bastante natural, sem exageros", conta Ivete Sangalo.

Há 18 anos no mercado de estética, o bioestimulador de colágeno Sculptra® estimula o aumento de produção dessa proteína em 66,5%¹*, que é a principal responsável por garantir a firmeza e sustentação da pele. Seus efeitos são duradouros e progressivos, podendo durar até 25 meses².

Segundo a dermatologista Dra. Livia Campelo (CRM-BA 17239) "O bioestimulador de colágeno é bastante seguro, eficaz e versátil, pois pode ser aplicado no rosto, pescoço, braços, abdômen, coxas, joelhos e glúteos".

Claudia Leitte também declarou que realiza procedimentos estéticos com Sculptra®: "Por mais que eu me exercite bastante para manter meu condicionamento físico e para ganhar massa muscular, acredito que quanto mais cuidado tivermos com o nosso corpo, com a nossa pele, melhor. O bioestimulador de colágeno ajuda muito nisso. De forma natural, o nosso corpo vai diminuindo a produção de colágeno, então conto com a ajuda do Sculptra®, que me garante resultados mais duradouros e contribuem com a melhora da qualidade da pele de forma natural".

A dermatologista Dra. Marina Horne (CRM-BA 20573) explica que "O procedimento com bioestimulador de colágeno é realizado de forma injetável e em consultório. O produto ajuda a melhorar a firmeza e sustentação da pele de forma bastante natural e pode ser aplicado tanto na lateral da face, como em algumas regiões do corpo. No bumbum, por exemplo, além de ajudar na firmeza dos glúteos, o bioestimulador ainda pode ser utilizado para amenizar celulite relacionada à flacidez, empinar ou volumizar a região".

Sabrina Sato é outra celebridade que não vive sem Sculptra® para manter a qualidade da pele, que esbanja firmeza enquanto a apresentadora samba como rainha de bateria da Vila Isabel e Gaviões da Fiel. Mas a musa também faz uso do ácido hialurônico injetável Restylane®.  "Eu comecei a usar Sculptra® depois da minha gravidez e desde então não parei (risos). Mas, além disso, meu médico indicou aplicação de Restylane® para amenizar algumas linhas de expressão, volumizar e hidratar meus lábios. Meu dermatologista me explicou que o ácido hialurônico presente em Restylane® é muito semelhante ao que o nosso próprio corpo produz, portanto, os resultados são mais naturais e seguros. E, realmente, os resultados são bem incríveis e naturais", conta Sabrina.

Restylane® é o portfólio de ácido hialurônico injetável mais seguro³, completo4 e utilizado do mercado5 capaz de amenizar rugas, olheiras, definir o contorno facial e dar volume aos lábios por meio de seus preenchedores a base de ácido hialurônico, e promover hidratação da pele e amenizar linhas finas e cicatrizes de acne por meio dos SkinboostersTM.

Médico responsável pela aplicação dos tratamentos na Sabrina Sato, o dermatologista Dr. Alberto Cordeiro (CRM-SP 125757) deu detalhes de como foram feitos os procedimentos no rosto e no corpo de Sabrina: "Na face, seguimos a abordagem Firm&LyftTM aplicando bioestimulador de colágeno na região lateral do rosto e preenchedor a base de ácido hialurônico nas maçãs da face. Assim, estimulamos a produção progressiva de colágeno e alcançamos um efeito lifting imediato. Ainda no rosto, também utilizei o ácido hialurônico injetável para volumizar e hidratar os lábios da Sabrina. Já no corpo, aplicamos bioestimulador de colágeno no bumbum para recuperar a firmeza da pele da região, amenizar a celulite relacionada à flacidez, empinar o bumbum e dar mais volume", explicou.

Sculptra® e Restylane® são produtos utilizados em procedimentos estéticos não cirúrgicos e pouco invasivos, que só podem ser realizados por profissionais da saúde habilitados à prática de injetáveis, capazes de avaliar qual tratamento é mais indicado para cada tipo de pele. Para acompanhar as novidades e ficar por dentro de tudo sobre estes produtos, acesse: https://linktr.ee/galderma.aesthetics.br

*Colágeno tipo l

¹Goldberg D, Guana A, Volk A, Daro-Kaftan E. Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013;39(6):915-922.
²Narins R, Baumann L, Brandt F et al. A randomized study of the efficacy and safety of Injectable poly-l-lactic acid versus human–based collagen implant in the treatment. J Am Acad Dermatol. 2010 Mar;62(3):448-62
³Sadeghpour M, et al. Delayed-Onset Nodules to Differentially Crosslinked Hyaluronic Acids: comparative Incidence and Risk Assessment. Dermatol Surg 2019;45:1085–1094
4Rzany B., Bayerl C., Bodokh I. et al. Eficacy and safety of a new hyaluronic acid dermal  filler in the treatment of moderate nasolabial folds: 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study. J Cosmet Laser Ther 2011;13:107-112
5Data on File.  Message Recall Aesthetics w2. HSR Health. Maio 2022

Sobre a Galderma 

A Galderma é a maior empresa independente de dermatologia do mundo, presente em aproximadamente 90 países. Desde a sua criação em 1981, tem sido movida por uma dedicação completa à Dermatologia, oferecendo um portfólio inovador e com base científica de marcas e serviços sofisticados em Estética, Produtos ao Consumidor e Medicamentos. Focada nas necessidades dos consumidores e pacientes, a Galderma trabalha em parceria com profissionais de saúde para garantir resultados superiores. As marcas de estética da Galderma foram consideradas, pelo segundo ano consecutivo, top of mind dos profissionais da saúde nas categorias Bioestimuladores de Colágeno e Ácido Hialurônico, segundo pesquisa realizada em 2022. A empresa segue avançando a dermatologia para cada história de pele, porque entende que a pele em que estamos molda nossas histórias de vida. Para   mais informações, visite https://www.galdermaaesthetics.com.br/

Foto - https://mma.prnewswire.com/media/2001213/1.jpg

FONTE Galderma

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the establishment of its new U.S. headquarters in Miami, Florida,...

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new broadcast advertisement...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Health Care & Hospitals

Health Care & Hospitals

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.